RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Circular RNAs: roles in hepatocellular carcinoma immune regulation, implications in immunotherapy, and prospects for clinical translation.
Circular RNAs: roles in hepatocellular carcinoma immune regulation, implications in immunotherapy, and prospects for clinical translation.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
环状RNA(circRNA)正逐渐成为肝细胞癌(HCC)肿瘤免疫微环境(TIME)中的关键调控因子。尽管免疫治疗带来了变革性作用,但其疗效仍受到原发性和获得性耐药的限制,这是当前研究尚未完全解决的难题。本综述独特地综合了最新证据,阐明特定circRNA如何通过两条相互关联的轴线在HCC中编排免疫抑制:(1)直接调控关键免疫细胞(如T细胞、NK细胞、巨噬细胞)的功能和极化,以及(2)干扰核心免疫相关信号通路(如NF-κB、MAPK、Wnt/β-catenin)。
我们批判性地审视了这些机制如何共同驱动免疫逃逸并赋予对免疫检查点抑制剂的耐药性。在机制探讨之外,我们进一步探索了circRNA的双重转化潜力:作为稳定、微创的诊断/预后生物标志物,以及通过RNA干扰或基于circRNA的疫苗策略作为新型治疗靶点。通过将基础分子见解与临床挑战相连接,本综述为理解circRNA驱动的HCC免疫调控提供了一个连贯的框架,并突出了克服免疫治疗耐药性的有前景的途径。
Circular RNAs (circRNAs) are emerging as pivotal regulators within the tumor immune microenvironment (TIME) of hepatocellular carcinoma (HCC). Despite the transformative role of immunotherapy, its efficacy remains limited by primary and acquired resistance, a challenge not fully addressed by current research.
This review uniquely synthesizes the latest evidence to delineate how specific circRNAs orchestrate immunosuppression in HCC through two interconnected axes: (1) by directly modulating the function and polarization of key immune cells (e. g. , T cells, NK cells, macrophages), and (2) by interfering with core immune-related signaling pathways (e. g. , NF-κB, MAPK, Wnt/β-catenin).
We critically examine how these mechanisms collectively fuel immune evasion and confer resistance to immune checkpoint inhibitors. Moving beyond mechanism, we further explore the dual translational potential of circRNAs: as stable, minimally invasive diagnostic/prognostic biomarkers and as novel therapeutic targets via RNA interference or circRNA-based vaccine strategies.
By connecting fundamental molecular insights to clinical challenges, this review provides a cohesive framework for understanding circRNA-driven immunomodulation in HCC and highlights promising avenues for overcoming immunotherapy resistance.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。